Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
5.20
-0.21 (-3.88%)
Nov 20, 2024, 4:00 PM EST - Market closed
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of $199.84 million as of November 21, 2024. Its market cap has increased by 36.94% in one year.
Market Cap
199.84M
Enterprise Value
40.74M
1-Year Change
36.94%
Ranking
Category
Stock Price
$5.20
Market Cap Chart
Since the IPO on February 21, 2018, Molecular Partners AG's market cap has decreased from $595.47M to $199.84M, a decrease of -66.44%. That is a compound annual growth rate of -14.93%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amarin Corporation | 203.37M |
| Inhibrx Biosciences | 203.24M |
| Acrivon Therapeutics | 202.39M |
| Lexeo Therapeutics | 202.36M |
| Orchestra BioMed Holdings | 200.71M |
| Neurogene | 199.19M |
| Editas Medicine | 198.94M |
| Quantum-Si incorporated | 198.37M |